Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer
EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in the development of bispecific antibodies, today announced […]
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer
Shattuck Labs, a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a […]
BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424
BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]
Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
Heron Therapeutics Announces New CEO and Board Chairman
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
SolasCure Announces Final Closing of £10.9m Series B Fundraise to Advance Wound Care Innovation
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which […]
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
CHARM Therapeutics, a 3D deep learning biotechnology company discovering and developing transformational medicines, today announced […]
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
Adiso Therapeutics Announces the Appointment of Srikar Guntaka, M.D., as Medical Director
Adiso Therapeutics, a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and […]
enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer
enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more